Page last updated: 2024-08-23

bromocriptine and Precancerous Conditions

bromocriptine has been researched along with Precancerous Conditions in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19908 (72.73)18.7374
1990's3 (27.27)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mori, T; Nagasawa, H1
Brown, CK; Goodrich-Smith, M; Johnson, D; Mackie, D; Welsch, CW1
Bridges, RS; Ho, SM; Lane, KE; Leav, I; Rand, WM; Ziar, J1
Anderson, TM; Brooks, CL; Brown, CK; Denenberg, B; Goodrich-Smith, M; Van, J; Welsch, CW1
Gullino, PM1
Medina, D1
Hassett, CC; Lambrecht, LK; Welsch, CW1
Welsch, CW2
Heppner, GH; Loeffler, DA; Tsai, SJ1
Fujimoto, NA; Ito, A; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Wada, S1

Other Studies

11 other study(ies) available for bromocriptine and Precancerous Conditions

ArticleYear
Alteration of the development of mammary hyperplastic alveolar nodules and uterine adenomyosis in SHN mice by different schedules of treatment with CB-154.
    Acta endocrinologica, 1984, Volume: 107, Issue:2

    Topics: Age Factors; Animals; Breast; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Endometriosis; Female; Hyperplasia; Mice; Mice, Inbred Strains; Precancerous Conditions; Time Factors; Uterine Neoplasms; Uterus

1984
2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
    Oncology, 1982, Volume: 39, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Rats; Rats, Inbred Strains; Tamoxifen; Time Factors

1982
Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
    Carcinogenesis, 1997, Volume: 18, Issue:8

    Topics: Animals; Bromocriptine; Estrogen Antagonists; Immunohistochemistry; Male; Precancerous Conditions; Prolactin; Proliferating Cell Nuclear Antigen; Prostate; Rats; Receptors, Estrogen; Testosterone

1997
Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
    Journal of the National Cancer Institute, 1979, Volume: 63, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Prolactin; Rats; Time Factors

1979
Considerations on the preneoplastic lesions of the mammary gland.
    The American journal of pathology, 1977, Volume: 89, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast; Breast Neoplasms; Bromocriptine; Cell Transformation, Neoplastic; Cells, Cultured; Ergolines; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Neoplasm Transplantation; Precancerous Conditions; Transplantation, Heterologous; Urethane

1977
Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
    Journal of the National Cancer Institute, 1977, Volume: 58, Issue:4

    Topics: Animals; Bromocriptine; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Ovary; Precancerous Conditions; Pyrrolidines; Receptors, Androgen; Receptors, Estrogen; Testosterone; Transplantation, Isogeneic

1977
Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
    Journal of the National Cancer Institute, 1977, Volume: 58, Issue:4

    Topics: Adrenal Glands; Animals; Bromocriptine; Castration; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Precancerous Conditions; Prolactin

1977
Prolactin and the development and progression of early neoplastic mammary gland lesions.
    Cancer research, 1978, Volume: 38, Issue:11 Pt 2

    Topics: Animals; Breast Neoplasms; Bromocriptine; Castration; DNA, Neoplasm; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Mestranol; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Norethynodrel; Organ Culture Techniques; Ovary; Parity; Placental Lactogen; Precancerous Conditions; Pregnancy; Prolactin; Transplantation, Heterologous

1978
Prophylaxis of early preneoplastic lesions of the mammary gland.
    Cancer research, 1976, Volume: 36, Issue:7 PT 2

    Topics: Animals; Bromocriptine; Ergolines; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metergoline; Mice; Mice, Inbred C3H; Parity; Precancerous Conditions; Prolactin

1976
Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
    Cancer research, 1992, Apr-15, Volume: 52, Issue:8

    Topics: Animals; Bromocriptine; Drug Administration Schedule; Hyperplasia; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Precancerous Conditions; Prolactin

1992
Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis.
    Cancer letters, 1990, Volume: 53, Issue:2-3

    Topics: Aminobiphenyl Compounds; Animals; Bromocriptine; Carcinogens; Carcinoma; Cocarcinogenesis; Male; Neoplasm Metastasis; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Precancerous Conditions; Prolactin; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles

1990